Clinical Trials Sponsored by Allison O'Neill

Total 82 results

Allison O'Neill, MD

Recruiting

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Liver Cancer | Fibrolamellar Carcinoma | Hepatocellular Carcinoma, Childhood | Liver Cancer, Pediatric

United States
Allison Gibson

Completed

Platform-based Mild Cognitive Impairment (MCI) Trial

Mild Cognitive Impairment

United States
The Cleveland Clinic
CVS Caremark; O'Neill Foundation

Terminated

T-ABA Group Based Early Intervention For Parents of Children With ASD (T-ABA)

Autism

United States
Alison Stopeck

Recruiting

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant Chemotherapy

United States
Alison Schneider

Terminated

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients

Clostridium Difficile Diarrhea

United States
Alison Gernand
Penn State University

Completed

Cyclic Variation in Micronutrient Concentrations and Plasma Volume

Menstrual Cycle | Plasma Volume | Micronutrients

United States
University of Guelph
Alison Duncan

Completed

Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women

Healthy | Premenopausal Period
Alison Morris

Completed

Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center (SPARC)

HIV Seropositivity

United States
Alison Ehrlich

Completed

Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis

Calcinosis

United States
Eleison Pharmaceuticals LLC.

Terminated

Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

Ovarian Cancer

United States
Eleison Pharmaceuticals LLC.

Recruiting

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Metastatic Pancreatic Adenocarcinoma

United States
Eleison Pharmaceuticals LLC.

Completed

Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma

Pulmonary Relapse of Osteosarcoma

United States
Spine Centre of Southern Denmark
Berit Schiøttz-Christensen; Søren O'Neill; Gregory Kawchuk

Completed

What Determines a Positive Outcome of Spinal Manipulation for Persistent Low Back Pain: Stiffness or Pain Sensitivity? A Randomized Trial (POPS)

Low Back Pain | Pain, Chronic

Denmark
Olivia C. O'Reilly

Active, not recruiting

Telerehabilitation After Shoulder Arthroplasty

Rotator Cuff Tear Arthropathy | Arthropathy Shoulder | Arthritis Shoulder Glenohumoral Joint

United States
Allist Pharmaceuticals, Inc.

Not yet recruiting

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

NSCLC
Allist Pharmaceuticals, Inc.

Unknown

AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Advanced NSCLC

China
Allist Pharmaceuticals, Inc.

Completed

Study to Determine the Effect of Food on the Blood Levels of AST2818 Following Single Oral Doses in Healthy Male Volunteers

Healthy Male Volunteers

China
Kelly Allison
Novo Nordisk A/S

Terminated

Binge Eating Liraglutide Intervention (BELIEVE)

Binge-Eating Disorder

United States
Alison Stopeck
Amgen

Completed

Denosumab and MRI Breast Imaging (Dmab)

Breast Cancer

United States
Allist Pharmaceuticals, Inc.

Unknown

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer

NSCLC
Allist Pharmaceuticals, Inc.

Unknown

Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790M

Advanced NSCLC Patients With T790M

China
Allist Pharmaceuticals, Inc.

Recruiting

Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation (FAVOUR)

NSCLC

China
Allist Pharmaceuticals, Inc.

Not yet recruiting

To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (FORWARD)

Non-small Cell Lung Carcinoma
Allist Pharmaceuticals, Inc.

Withdrawn

Phase Ib Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation

NSCLC

China
Allist Pharmaceuticals, Inc.

Unknown

Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer （FLAG）

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer

China
Allist Pharmaceuticals, Inc.

Completed

Study Evaluating the Mass Balance And Biotransformation of Single Dose[14C] AST2818 in Chinese Healthy Male Volunteers

Healthy Male Volunteers

China
Brian O'Neill MD
Lifetech Scientific (Shenzhen) Co., Ltd.

Not yet recruiting

Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF (CORRAL-AF)

Atrial Fibrillation | Left Atrial Appendage Thrombosis | CVA

United States
Allison Williams
University of Pittsburgh Medical Center

Terminated

Steroid Use in Non-RSV Bronchiolitis

Bronchiolitis, Viral

United States
Allon Therapeutics

Completed

Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery

Mild Cognitive Impairment

United States, Canada
Allon Therapeutics

Completed

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

Progressive Supranuclear Palsy

United States, Australia, France, Canada, Germany, United Kingdom
Allon Therapeutics

Completed

Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment

Mild Cognitive Impairment, So Stated

United States
Allison Sylvetsky (Meni)
Children's National Research Institute

Completed

Effects of Low-calorie Sweetened Beverage Restriction in Youth With Type 1 Diabetes

Type 1 Diabetes

United States
Allison Magnuson
National Institute on Aging (NIA)

Active, not recruiting

Feasibility of the Memory and Attention Adaptation-Training Geriatrics Intervention in Older Cancer Survivors With Mild Cognitive Impairment (urochester)

Cognitive Dysfunction

United States
Alison Sehgal, MD, MS

Terminated

Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia

Leukemia, Acute Myelogenous

United States
Alison Fox-Robichaud

Completed

Studies of Blood DNA in Patients With Severe Infection DYNAMICS (DYNAMICS)

Sepsis | Shock | Trauma

Canada
Eleison Pharmaceuticals LLC.
Threshold Pharmaceuticals

Completed

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States
Aymes International Limited
Alison Clark Health and Nutrition

Completed

Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS)

Malnutrition
Alison Walker

Completed

AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States
Aymes International Limited
Alison Clark Health and Nutrition

Completed

Acceptability and Tolerance of New Oral Nutritional Supplement

Malnutrition
Alison Gustafson
East Carolina University

Completed

Shopping Smart - Adolescent Intervention to Improve Shopping Practices Where You Live and Learn

Food Choices

United States
Aymes International Limited
Alison Clark Health and Nutrition

Completed

Acceptability and Tolerance Study of New Oral Nutritional Supplement

Malnutrition
University of Minnesota
Friedreich's Ataxia Research Alliance; Bob Allison Ataxia Research Center

Completed

Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia

Friedreich Ataxia

United States
Fudan University
Allist Pharmaceuticals, Inc.

Recruiting

Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE)

Non-Small-Cell Lung Cancer

China
Albion
Sprim Advanced Life Sciences

Unknown

A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

Anemia

Indonesia
Allison Kennedy
AFP Innovation Fund; Mach Gaensslen Foundation

Completed

Building Resilience and Attachment in Vulnerable Adolescents (BRAVA)

Suicidal Ideation

Canada
University of Washington
National Institute on Aging (NIA); Ellison Foundation

Not yet recruiting

University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker Core

Alzheimer Disease
Alison Stopeck
Eli Lilly and Company; AstraZeneca

Withdrawn

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Locally Advanced Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female

United States
Alison Walker
Seagen Inc.

Terminated

Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

Myelodysplastic Syndromes | Leukemia

United States
University of South Florida
Pfizer; National Ataxia Foundation; Bob Allison Ataxia Research Center (BAARC)

Completed

Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

Spinocerebellar Ataxia Type 3

United States
ArriVent BioPharma, Inc.
Allist Pharmaceuticals, Inc.

Recruiting

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

Advanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 Mutations

United States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom

Clinical Trials Sponsored by Allison O'Neill

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations